iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 125.35 billion as of May 15, 2025. Its market cap has decreased by -46.51% in one year.

Market Cap

125.35B

Enterprise Value

76.82B

Revenue

6.42B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,965.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 125.35B, an increase of 31.53%. That is a compound annual growth rate of 1.93%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	126.46B	-31.11%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	70.53T
Celltrion	32.36T
ALTEOGEN	17.91T
Yuhan	7,864.20B
HLB Co., Ltd.	7,463.37B
SK Biopharmaceuticals	6,930.72B
PharmaResearch	4,171.44B
Peptron	3,983.85B

Market Cap Rankings